Vedolizumab: A New Opponent in the Battle Against Crohns Disease and Ulcerative Colitis
This article serves as a summary of efficacy, safety, and other relevant information from clinical studies to explore the role of vedolizumab in the treatment of CD and UC.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Poulakos, M., Machin, J. D., Pauly, J., Grace, Y. Tags: Review Articles Source Type: research
More News: Brain | Clinical Trials | Crohn's Disease | Disability | Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Neurology | Study | Toxicology | Tysabri | Ulcerative Colitis